A. Colbert

Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs

S. Pederson, V. Chow, Lei Zhou, 2014, mAbs.

Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor

L. Gibiansky, T. Vu, C. Banfield, 2011, Pharmaceutical Research.

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.

Preclinical development of AMG 139, a human antibody specifically targeting IL‐23

J. Gow, Y. Sun, Y. Zhang, 2015, British journal of pharmacology.

Abstract 10701: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145

A. Shaywitz, M. Retter, J. Gibbs, 2011 .

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.